---
schema_version: "secwatch.filing_event.v1"
accession: "0001071739-26-000154"
form_type: "8-K"
ticker: "CNC"
cik: "0001071739"
company_name: "CENTENE CORP"
filed_at: "2026-07-27T23:38:01+00:00"
generated_at: "2026-07-28T10:05:38.321414+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Centene Q2 GAAP EPS $2.19, adj. EPS $2.51; raises 2026 guidance; board changes

## Summary
- Q2 GAAP diluted EPS $2.19, adjusted diluted EPS $2.51; total revenues $53.6B, premium & service revenues $44.4B.
- Health benefits ratio improved to 89.6% from 93.0% YoY; Medicaid HBR 93.9%, Commercial 79.2%, Medicare 89.5%.
- 2026 guidance raised: GAAP diluted EPS >$3.11, adjusted diluted EPS >$4.80.
- Board changes: Kenneth Burdick resigned; Paul Diaz appointed effective July 28, 2026. Diaz is former CEO of Myriad Genetics and Kindred Healthcare.
- Repurchased $260M of senior notes due 2027/2028; total debt $16.1B; cash from operations $3.6B.

## SEC filing metadata
- accession: 0001071739-26-000154
- form_type: 8-K
- ticker: CNC
- cik: 0001071739
- company_name: CENTENE CORP
- filed_at: 2026-07-27T23:38:01+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1071739/000107173926000154/0001071739-26-000154-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1071739/000107173926000154/cnc-20260728.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001071739-26-000154
- JSON: https://secwatch.observer/filing/0001071739-26-000154.json
- Plain text: https://secwatch.observer/filing/0001071739-26-000154.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.